Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of SXTP will decline by -11.50% over the next 2 Weeks and hit $0.49 by Monday, January 12, 2026. In that time frame, SXTP's share price is expected to range between $0.41 and $0.57.
BearishAverageBullishSXTP shares fell -20.55% in Monday, December 29, 2025's trading session, dropping from a previous close of $0.70 to move at $0.55. The stock demonstrated notable intraday movement (see SXTP's key stats for a full breakdown), fluctuating between $0.53 and $0.73, a +36.65% trading range. While recent weeks have seen some volatility, SXTP has managed to secure a -35.22% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 756.22K shares changing hands, 560.49K more than the previous session. This amounted to $418.19K in total market activity.
Will SXTP Continue Its Upward Trend?
According to analyst ratings and projections for SXTP, 60 Degrees Pharmaceuticals, Inc. shares are anticipated to increase by +2.24%, potentially reaching $0.57 per share by January 12, 2026. Short-term technical indicators currently suggest a neutral sentiment for SXTP. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the SXTP stock forecast, now is a good time to buy SXTP stock because its current trading price is +13.00% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on SXTP covering social and institutional perspectives.
SXTP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into SXTP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 13.45% to 22.90%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 36.04%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 55.38%, maintains a neutral outlook for the long term. Insights into SXTP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
60 Degrees Pharmaceuticals Short-Term Forecasts
SXTP Forecast For Next 5 Days
Our algorithm anticipates 60 Degrees Pharmaceuticals (SXTP) stock could hit $0.55 by Jan 05, 2026. This represents a -1.27% fall from today's price, following a -27.14% change over the past five days.
SXTP Forecast For Next 30 Days
Based on analysis of market trends, the outlook for 60 Degrees Pharmaceuticals, Inc. (SXTP) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.50, which would mean a -9.58% decrease from the current price of $0.55. Projections for this period range from a high of $0.69 to a low of $0.28.
SXTP Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for 60 Degrees Pharmaceuticals's price over the next three months point to a drop. SXTP stock is expected to peak at $1.94 on Dec 30, 2025 before potentially dipping to $0.00 on Mar 27, 2026. On average, SXTP is likely to trade around $0.33 in the coming 90 days.
60 Degrees Pharmaceuticals Stock Forecast 2025
Based on our predictive models, 60 Degrees Pharmaceuticals (SXTP) is expected to trade between $0.00 and $1.94 throughout 2025. This would result in an average price of $0.88, potentially offering investors a +59.13% return from current levels.
60 Degrees Pharmaceuticals, Inc. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, 60 Degrees Pharmaceuticals, Inc. (SXTP) is positioned to show a strong performance in December 2025. The price is predicted to move between $0.00 and $1.94, settling at an average of $0.88. This could translate to a +59.13% gain.
January 2026
Based on current market signals, 60 Degrees Pharmaceuticals, Inc. is projected to trend january 2026. We forecast a trading range from $0.00 to $1.92, with a likely average price of $0.64. Investors could expect a potential return of +15.73%.
February 2026
Our predictive algorithms indicate 60 Degrees Pharmaceuticals, Inc. stock may see a shift in February 2026. The expected range spans $0.00–$1.55, with an average target of $0.11. This represents a cautious outlook and a possible loss of -80.11%.
March 2026
Analyzing established trends, 60 Degrees Pharmaceuticals, Inc. looks set to move in March 2026. Projections place the stock between $0.00 and $1.50, averaging around $0.15. This suggests a -72.88% loss from current levels.
April 2026
Market indicators suggest 60 Degrees Pharmaceuticals, Inc. could experience notable changes during April 2026. Prices could fluctuate within $0.00 to $1.52, with a midpoint forecast of $0.14. The stock might deliver a -74.68% loss.
May 2026
Forecasting for May 2026, models estimate that 60 Degrees Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.50, averaging $0.22. This signals a cautious trajectory with potential returns around -60.22%.
June 2026
According to our latest forecast models, 60 Degrees Pharmaceuticals, Inc. (SXTP) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.00 and $1.59, settling at an average of $0.22. This could translate to a -60.22% loss.
July 2026
Based on current market signals, 60 Degrees Pharmaceuticals, Inc. is projected to trend july 2026. We forecast a trading range from $0.00 to $1.38, with a likely average price of $0.15. Investors could expect a potential return of -72.88%.
August 2026
Our predictive algorithms indicate 60 Degrees Pharmaceuticals, Inc. stock may see a shift in August 2026. The expected range spans $0.00–$1.40, with an average target of $0.06. This represents a cautious outlook and a possible loss of -89.15%.
September 2026
Analyzing established trends, 60 Degrees Pharmaceuticals, Inc. looks set to move in September 2026. Projections place the stock between $0.00 and $1.43, averaging around $0.05. This suggests a -90.96% loss from current levels.
October 2026
Market indicators suggest 60 Degrees Pharmaceuticals, Inc. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $1.39, with a midpoint forecast of $0.05. The stock might deliver a -90.96% loss.
November 2026
Forecasting for November 2026, models estimate that 60 Degrees Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.37, averaging $0.04. This signals a cautious trajectory with potential returns around -92.77%.
December 2026
According to our latest forecast models, 60 Degrees Pharmaceuticals, Inc. (SXTP) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $1.31, settling at an average of $0.06. This could translate to a -89.15% loss.
SXTP's history of dividends and stock splits also plays a role in long-term investor confidence.

